| Literature DB >> 32912275 |
Eunice Oluwatobiloba Adedeji1,2, Olubanke Olujoke Ogunlana1,2, Segun Fatumo3, Thomas Beder4, Yvonne Ajamma1, Rainer Koenig5, Ezekiel Adebiyi6,7,8.
Abstract
The increasing resistance to currently available insecticides in the malaria vector, Anopheles mosquitoes, hampers their use as an effective vector control strategy for the prevention of malaria transmission. Therefore, there is need for new insecticides and/or alternative vector control strategies, the development of which relies on the identification of possible targets in Anopheles. Some known and promising targets for the prevention or control of malaria transmission exist among Anopheles metabolic proteins. This review aims to elucidate the current and potential contribution of Anopheles metabolic proteins to malaria transmission and control. Highlighted are the roles of metabolic proteins as insecticide targets, in blood digestion and immune response as well as their contribution to insecticide resistance and Plasmodium parasite development. Furthermore, strategies by which these metabolic proteins can be utilized for vector control are described. Inhibitors of Anopheles metabolic proteins that are designed based on target specificity can yield insecticides with no significant toxicity to non-target species. These metabolic modulators combined with each other or with synergists, sterilants, and transmission-blocking agents in a single product, can yield potent malaria intervention strategies. These combinations can provide multiple means of controlling the vector. Also, they can help to slow down the development of insecticide resistance. Moreover, some metabolic proteins can be modulated for mosquito population replacement or suppression strategies, which will significantly help to curb malaria transmission.Entities:
Keywords: Acetylcholinesterase; Immune response; Insecticide; Insecticide resistance; Plasmodium; Vector control
Mesh:
Substances:
Year: 2020 PMID: 32912275 PMCID: PMC7488410 DOI: 10.1186/s13071-020-04342-5
Source DB: PubMed Journal: Parasit Vectors ISSN: 1756-3305 Impact factor: 3.876
Fig. 1Role of Anopheles metabolic proteins in malaria transmission and control. Abbreviations: PAH, phenylalanine-4-hydroxylase; AChE, acetylcholinesterase; CYP 450s, cytochrome P450s; AQP3, aquaporin 3; GSTs, glutathione S-transferases; HPX2, heme peroxidase 2; NOX5, NADPH oxidase 5; NOS, nitric oxide synthase; PO, phenoloxidase; TreT1, trehalose transporter; KMO, kynurenine 3-monooxygenase; CEs, carboxylesterases
Fig. 2Conserved catalytic serine residue in acetylcholinesterase (AChE) targeted by insecticides in diverse organisms. The sequences shown are from Drosophila melanogaster (DROME), Tetronarce californica (TETCF), Mus musculus (MOUSE), Homo sapiens (HUMAN), Bos taurus (BOVIN), Rattus norvegicus (RAT), Caenorhabditis elegans (CAEEL), An. stephensi (ANOST), An. gambiae (ANOGA), Culex pipiens (CULPI), An. sinensis (ANOSI), Aedes aegypti (AEDAE). The name of each organism starts with its UniProt accession number. Conserved catalytic serine is shown by a black arrow. The catalytic serine residue is conserved across insects (1–2 and 4–7), mammals (10–13), birds (9), nematode (3) and fish (8). * indicates positions that have single and conserved amino acid residues; : indicates conservation between amino acid residues of strongly similar properties; . indicates conservation between amino acid residues of weakly similar properties
Fig. 3Paraoxon binds conserved residues in both humans’ and mosquitoes’ acetylcholinesterase (AChE), hence toxic to humans. Diethyl phosphonate (DEP) from paraoxon binds covalently to Ser203 in humans AChE (hAChE; PDB ID: 5hf5) and Ser360 in An. gambiae AChE (AgAChE; PDB ID: 5x61), thus inhibiting them. Covalent binding is highlighted in black dotted circle. Also, DEP interacts with Gly122, His447 and Ala204 in hAChE, Gly280, His600 and Ala361 in AgAChE through hydrogen bonds
Classes of insecticides, their resistance mechanisms and associated proteins in Anopheles species
| Insecticide class | Resistance mechanism and associated proteins | |
|---|---|---|
| Target site | Metabolic resistance | |
| Organophosphates | AChE-G119S in | GSTE2 in |
| α- and β-esterases in | ||
| Organochlorines, e.g. DDT | Target site is not a metabolic protein | CYP6M2, CYP6P3, GSTD3, GSTE2, in |
| CYP6P9a, CYP6P9b, GSTD1-5, GSTD3, GSTE2, α-esterase in | ||
| Pyrethroids | Target site is not a metabolic protein | CYP4G16 (cuticular resistance), CYP6M2, CYP6P3, CYP6Z2, COEAE1D, GSTE2, GSTD1, GSTD3, GSTE4 in |
| CYP6M7, CYP6P9a, CYP6P9b, CYP6P4, CYP9J11, CYP9K1 in | ||
| CYP6AA3 and CYP6P7 in | ||
| CYP325C1, GSTS1-1, GSTS1-2, GSTMIC2, COEJHE2, AnstABCB2, AnstABCBmember6, AnstABCG4 in | ||
| CYP6P1, CYP6Z1, CYP6Z3, CYP9K1, CYP9J5, CYP9M1, GSTE2, GSTE5, GSTM1, GSTMS3, GSTS1-2, GSTS1-1, GSTE4, COEAE3G, COEAE4G, COEAE5G in | ||
| CYP6AG2, CYPZ1, TPX2, CYPZ2, CYP6P1, CYP6P4, GSTE4 in | ||
| CYP4H14, CYP6AA1, CYP6M3, CYP6M17, CYP6P2, α-esterase 10, AChE1 in | ||
| CYP4C26, CYP6P5, CYP9K1 in | ||
| Carbamates | AChE-G119S in | CYP4H17, CYP6P3, CYP6Z3, CYP6Z1, CYP12F2, CYP6M3 CYP6P4, GSTD3 in |
| CYP6M2, CYP6P3, CYP6Z1 in | ||
Fig. 4Conserved unpaired cysteine residue in the acetylcholinesterase (AChE) of disease vectors for selective insecticide design. The sequences shown are from Drosophila melanogaster (DROME), Tetronarce californica (TETCF), Mus musculus (MOUSE), Homo sapiens (HUMAN), Bos taurus (BOVIN), Rattus norvegicus (RAT), Caenorhabditis elegans (CAEEL), Anopheles stephensi (ANOST), An. gambiae (ANOGA), Culex pipiens (CULPI), An. sinensis (ANOSI), Aedes aegypti (AEDAE). The name of each organism starts with its UniProt accession number. The black arrow points to the position of the conserved unpaired cysteine residue. The unpaired cysteine residue is conserved in disease vectors (4–7). This residue is substituted by a leucine residue in An. stephensi and Drosophila AChE (1–2), phenylalanine residues in mammals, fish and bird AChE (8–13), and a glycine residue in nematode AChE (3). This unpaired cysteine could be targeted for the development of more selective and specific insecticides. * indicates positions that have single and conserved amino acid residues; : indicates conservation between amino acid residues of strongly similar properties; . indicates conservation between amino acid residues of weakly similar properties
Efficacy of alphacypermethrin and chlorfenapyr mixture in insecticide treated nets
| Reference | Camara et al. [ | Bayili et al. [ | NʼGuessan et al. [ | NʼGuessan et al. [ | Oxborough et al. [ | |||
|---|---|---|---|---|---|---|---|---|
| Mosquito strain & (location) | ||||||||
| Pyrethroid resistance intensity (folds) | 450.2 (for Alpha). Over 1700 (for deltamethrin) | Over 1000 | 207 (for Alpha) | 207 | ||||
| Insecticide | Alpha (mg/m2) | 200 on Interceptor® | 200 on Interceptor® | 200 on Interceptor® | 25 | 25 | ||
| CFP (mg/m2) | 200 | 200 | 200 | 200 | 100 | |||
| Alpha + CFP (mg/m2) | 100 + 200 on Interceptor® G2 | 100 + 200 on Interceptor® G2 | 100 + 200 on Interceptor® G2 | 25 + 100 | 25 + 200 | 25 + 100 | ||
| Mortality at 72 h# (%) | Alpha | Unwashed | 10a | 17 | 20 | 30 | 50f | |
| Washed 20 times | 11a | 10 | 13 | nd | nd | |||
| CFP | 92b | 86d | 76 | 69e | 48f | |||
| Alpha + CFP | Unwashed | 87b,c | 78d | 71 | 75e | 77e | 58f | |
| Washed 20 times | 82c | 76d | 65 | nd | nd | nd | ||
| Blood-feeding inhibition## (%) | Alpha | Unwashed | ns | 26a,b,c | 57d | 22f | 52g | |
| Washed 20 times | ns | 15a | 47e | nd | nd | |||
| CFP | 54 | 21a,c | 43e | ns | 72g | |||
| Alpha + CFP | Unwashed | 43 | 42b | 60d | 51 | 35f | 76g | |
| Washed 20 times | 34 | 32b,c | 50d,e | nd | nd | nd | ||
| Personal protection### (%) | Alpha | Unwashed | 57a,c | 24d | 62.5e | 39 | nd | |
| Washed 20 times | 47c | 14d | 22f | nd | nd | |||
| CFP | 76b | 22d | 36.7g | 23 | nd | |||
| Alpha + CFP | Unwashed | 71a,b | 44d | 59.2e | 62 | 58 | nd | |
| Washed 20 times | 60a | 34d | 34.4f,g | nd | nd | nd | ||
Abbreviations: Alpha, alphacypermethrin; CFP, chlorfenapyr; ns, not significant, nd: not determined in the study
For each row (, and ), where provided, numbers in the same column (from the same study) sharing a letter superscript do not differ significantly (P > 0.05). For resistance status of An. arabiensis in Tanzania, percentage mortality of 58 and 76 were observed for lambda cyhalothrin and permethrin (both pyrethroids)
Efficacy of pyrethoids and synergist mixture in insecticide treated nets
| Reference | Mosquito strain & (location) | Pyrethroid resistance intensity | Insecticide treated net (ITNs) | Mortality at 72 h# (%) | Blood-feeding inhibition# (%) | Personal protection### (%) | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Pyrethroid | Pyrethroid + PBO | Untreated nets | Pyrethroid | Pyrethroid + PBO | Pyrethroid | Pyrethroid + PBO | Pyrethroid | Pyrethroid + PBO | |||||
| Unwashed | Washed 20 times | Unwashed | Washed 20 times | ||||||||||
| Menze et al. [ | Mortality rates of around 48.88 ± 5.76% for permethrin and around 38.34 ± 5.79% for deltamethrin [ | Olyset | Olyset Plus | 5.4a | 9.7a | nd | 25.1 | nd | 62.37b | 55.63b | 83.01d | 77.35d | |
| PermaNet 2.0 | PermaNet 3.0 | 12.2 | nd | 30.1 | nd | 51.36 | 61.52 | 70.44c | 84.90c | ||||
| Oumbouke et al. [ | Mortality rates of 68% for alpha-cypermethrin | MAGNet® | VEERALIN® | 2.3 | 29 | 17.3 | 51 | 38.2 | 35.5 | 62.7 | 69 | 87.1 | |
| Toe et al. [ | Mortality rates of < 14% for permethrin and < 33% for deltamethrin | PermaNet 2.0 | PermaNet 3.0 | 9.5 | 25.9 | nd | 46.1 | nd | nd | nd | nd | nd | |
| Olyset | Olyset Plus | 21.8 | nd | 36.9 | nd | nd | nd | nd | nd | ||||
| Pennetier et al. [ | Olyset | Olyset Plus | 0 | 42a | 36a | 81b | 67b | 82 | 83 | nd | nd | ||
| Corbel et al. [ | 23% mortality to deltamethrin L1014F kdr mutation (> 80%) | PermaNet 2.0 | PermaNet 3.0 | 4.9 | 44.4a | 30.2 | 78.2 | 49.3a | 53.4 | 72.6 | 83 | 86 | |
| (Malanville, Benin) | 85% mortality to deltamethrin. 16% L1014F kdr mutation Metabolic resistance (oxidase) | 4.2 | 88.8 | 70.7a | 96.7 | 70.0a | 90.1 | 98.7 | 91.6 | 99.1 | |||
| (Pitoa, Cameroon) | 70% mortality to deltamethrin. < 5% L1014F kdr mutation. Metabolic resistance (oxidase + esterase) | 12.9 | 82.9a | 56.5 | 93.8 | 77.9a | 70.8 | 46.1 | 92.3 | 80.4 | |||
Abbreviations: nd, not determined in the study; PBO, piperonyl butoxide. For each column (, , and ), where provided, numbers in the same row (from the same study) sharing a letter superscript do not differ significantly (P > 0.05). The insecticide contained in each ITN are as follows: Olyset contains Permethrin; Olyset Plus contains Permethrin + PBO; PermaNet 2.0 contains Deltamethrin; PermaNet 3.0 contains Deltamethrin + PBO; MAGNet® contains Alpha-cypermethrin; VEERALIN® contains Alpha-cypermethrin + PBO
Fig. 5Ways of manipulating metabolic proteins of Anopheles for vector control strategies. Abbreviations: AChE, acetylcholinesterase; CYP 450, cytochrome P450; GST, glutathione S-transferases; 3HKT, 3-hydroxykynurenine transaminase; KMO, kynurenine 3-monooxygenase; NOS, nitric oxide synthase; PO, phenoloxidase; CP, carboxypeptidase
Possible Anopheles’ metabolic proteins for vector control strategies based on their role in malaria transmission
| Role in malaria transmission | Metabolic protein | Possible intervention strategy |
|---|---|---|
| Destruction of | Chymotrypsina [ | Genetic modification: development of refractory mosquitoes with enhanced expression of proteins post blood-feeding. Prevention of peritrophic membrane development |
| Trypsina [ | ||
| Enhances immune response to | Phenylalanine-4-hydroxylasea (PAH) [ | Genetic modification: development of refractory mosquitoes with increased expression of proteins post blood-feeding |
| Nitric oxide synthaseb (NOS) [ | ||
| Enhances | Carboxypeptidasea [ | Transmission-blocking agents: inhibition of proteins provides transmission-blocking strategies. Carboxypeptidase can be already targeted using antibodies [ |
| Kynurenine 3-monooxygenasea [ | ||
| 3-hydroxykynurenine transaminasea [ | ||
| Ornithine decarboxylasea [ | ||
| Aquaporin 3 [ | ||
| Trehalose transporterc [ | ||
| Catalaseb [ | ||
| Vitellogenind [ | ||
| Lipophorind [ | ||
| Apolipophorind [ | ||
| Fecundity | Phenylalanine-4-hydroxylase (PAH)a [ | Sterilants: inhibition may offer sterilizing strategies |
| Ornithine decarboxylasea [ | ||
| Heme oxygenase [ | ||
| Vitellogenind [ | ||
| Catalaseb [ | ||
| Energy production during flight | Trehalasec [ | Flight inhibitors: inhibition may provide flight inhibition strategies |
| Pyrroline-5-carboxylate reductasea [ | ||
| Proline oxidasea [ | ||
| Insecticide resistance | Cytochrome P450 monooxygenasese [ | Synergists: inhibitors may reverse insecticide resistance |
| Glutathione S-transferasese [ | ||
| Survival or development of mosquitoes | Aquaporin 3 [ | Insecticides: inhibitors may act as insecticides |
| Catalaseb [ | ||
| 3-hydroxykynurenine transaminasea [ | ||
| Carbonic anhydrase [ | ||
| Arylalkylamine N-acetyltransferases [ | ||
| Chorion peroxidase [ | ||
| V-ATPases [ | ||
| Phosphofructokinasec [ |
aProtein involved in protein/amino acid metabolism
bProtein involved in metabolism of reactive oxygen species
cProtein involved in carbohydrate metabolism
dProtein involved in lipid metabolism
eProtein involved in xenobiotic metabolism